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TO THE EDITOR
Silver sulfadiazine (SSD) is considered
the gold standard for burn treatment. As
a broad spectrum antimicrobial agent it
can prevent infection and accelerate
wound healing by lowering bacterial
burden. Although SSD is widely used
in the clinical space, several studies
have demonstrated its inferiority when
compared with other wound healing
adjuvants (Genuino et al., 2014;
Rashaan et al., 2014). Given these
findings, the following report aims to
elucidate SSD’s impact on wound
healing and suggest mechanisms by
which this activity occurs.
Topical SSD applied to burns signifi-
cantly delayed wound closure com-
pared with controls (Figure 1a). By
day 3, controls and SSD-treated wounds
expanded as compared with day 0;
however, the extent was significantly
greater in the SSD-treated group (49.7
vs 23.8%, Po0.0002). By day 10, the
SSD-treated group demonstrated 16.3%
closure compared with 42.1% closure
in controls (Po0.005; Figure 1b).
Hematoxylin and eosin (H&E) stain-
ing of SSD-treated tissue at day 7
showed a pink homogenized collection
of thermally damaged structures with
minimal dermal reconstruction com-
pared with control. By day 15,
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Figure 1. Silver sulfadiazine delays wound closure. (a) Wounds of BALB/c mice untreated (upper panel) or treated with silver sulfadiazine (SSD; lower panel) on
days 0, 7, and 13. Bar¼5 mm. These experiments were performed three times with similar results. (b) Wound size analysis of BALB/c mice skin lesions. Time
points are the averages of the results for 56 and 46 treated measurements for untreated controls and SSD, respectively, and error bars denote SEMs. *Po0.05 in
comparing the SSD-treated to -untreated groups. (c) Histological analysis of untreated and SSD-treated BALB/c mice at day 7 and 15. Hematoxylin & Eosin
staining. Scale bars left to right: 1000mm, 100mm. Blue staining indicated collagen utilizing Trichome. Scale bar¼100mm.
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SSD-treated wounds showed a persistent
crust overlying incomplete re-epithelia-
lized epidermis (Figure 1c). On day 7,
minimal blue staining was seen in the
dermis in both groups on Masson’s
Trichrome. At day 15, intensity of blue
staining was greater in the untreated
group, indicating delayed collagen
deposition in the SSD-treated tissue.
Immunohistochemistry revealed more
and persistent inflammatory granulation
tissue in the wound as compared with
controls over time, with increased neu-
trophil and decreased macrophage infil-
tration identified by myeloperoxidase
(MPO) and ionized calcium-binding
adapter molecule-1 (IBA-1) staining,
respectively, in the SSD-treated group
(Figure 2a).
Cytokine analysis on day 3 showed
the absence of several proinflammatory
factors including monocyte chemo-
tactic protein (MCP)-1, macrophage
inflammatory protein(MIP)-1a, and inter-
leukin-1 receptor antagonist(IL-1ra),
which were present in untreated tissue
(Figure 2b). Expression levels of interleu-
kin (IL)-1a and macrophage inflammatory
protein (MIP)-2 were significantly lower
compared with controls. On day 7, sig-
nificantly lower levels of IL-1a, IL-1ra,
MIP-1a, and MIP-2 were noted in the
SSD group with complete absence of
MCP-1.
Our findings have several implica-
tions for the mechanism by which SSD
impedes wound healing, although it is
important to note that the translatability
of murine data to humans is question-
able (Seok et al., 2013). The inflam-
matory reaction in wound healing is
regulated by a delicate balance
between pro- and anti-inflammatory
cytokines. IL-1a, IL-b, and IL-1ra are
located on chromosome 2 as part of
the IL-1 gene complex. The IL-1 family
regulates chemokine production by
keratinocytes, fibroblasts, and macro-
phages. IL-1ra serves as an important
regulator of IL-1’s proinflammatory
activity by direct receptor antago-
nism(Ishida et al., 2006). Transcription
of these cytokines is heavily influenced
by the presence of other family
members—with IL-1a and IL-b enhan-
cing their own gene expression and IL-
1ra attenuating the expression of IL-1
mRNA (Watson et al., 1995; Weber
et al., 2010). The tightly controlled
balance of IL-1 and IL-1ra is critical for
proper biological function (Arend, 2002).
Although IL-1 is necessary for wound
healing, over- and underproduction
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Figure 2. Silver sulfadiazine alters the immunologic milieu in burn wounds. (a) Histological analysis of untreated and silver sulfadiazine (SSD)-treated wounded
BALB/c mice at day 7. Representative myeloperoxidase (MPO)—(left) and IBA-1—(right) immunostained sections of the burn lesions are shown. The brown
staining indicates cellular infiltration into the wound bed. Scale bars¼1000 and 100mm(left to right). (b) First row: Number of neutrophils and macrophages per
field in wounded skin tissue of untreated and SSD mice. Data are given as the average number of neutrophils and macrophages in 15 different fields for 20 different
wounds, and error bars denote SEMs. *Po0.0001 in comparing the SSD-treated group with the untreated groups. Second row: Quantification of signals from
wounds (n¼10 per group) on days 3 and 7. The blots were scanned and signal intensity was measured. IL-1a, IL-1ra, MIP-1a, and MIP-2. (Notably, as antibodies
specific for each individual cytokine are used in this cytokine array, absolute levels for different cytokines cannot be compared.) Error bars denote SEMs.
*Po0.0001 in comparing the SSD-treated group with the untreated groups.
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have been linked to impaired wound
closure in vivo (Hu¨bner et al., 1996;
Zhang et al., 2004). A limited but early
rise followed by sustained increases in
IL-1 overtime are beneficial for wound
healing (Jurjus et al., 2007). Similarly,
decreased levels of IL-1ra have been
linked to impaired wound healing,
demonstrating delayed collagen and
granulation tissue formation (Ishida
et al., 2006). Our experiment revealed
significantly decreased levels of IL-1 and
IL-1ra in SSD-treated wounds throughout
the experiment. Although expression of
these cytokines is dependent on the
complex interplay between them, we
hypothesize that SSD dampens IL-1
gene expression globally. The mech-
anism of this relationship remains
unclear, warranting further investigation.
Several monocyte-related chemokines
were also significantly suppressed.
MCP-1, MIP-1a, and MIP-2 are potent,
collaborative chemoattractants for
monocytes, integral for the formation
of new tissue (DiPietro et al., 1998).
MCP-1-deficient mice exhibit delayed
wound re-epithelialization, angioge-
nesis, and collagen synthesis, despite
comparable levels of monocytes when
compared with controls, implying
impaired monocyte activation (Low
et al., 2001). In vivo studies using anti-
MIP-1a antiserum-treated mice showed
decreased macrophage recruitment,
angiogenic activity, and collagen syn-
thesis compared with controls (DiPietro
et al., 1998). Conversely, elevated levels
of MIP-2 are correlated with accelerated
wound healing (Babcock et al., 2012).
Histologically, SSD-treated burns
demonstrated less macrophage infiltra-
tion, which likely corresponds to the
decrease in the three aforementioned
chemokines. Neutrophils, however,
enter the wound bed through passive
extravasation following injury, not
requiring chemotactic recruitment for
wound infiltration. Importantly, the
persistent neutrophil burden visualized
histologically likely resulted from
decreased macrophage recruitment,
whose production and signalizing via
nitric oxide is required for the transition/
progression of wound healing (Hossain
et al., 2012). Interestingly, IL-1 signaling
is required for the production of MCP-
1(Tran et al., 1996), MIP-2 (Xu et al.,
1995), and MIP-1a (Hu et al., 2010).
Therefore, the noted reduction in each
these cytokines may correlate with
SSD-induced dysregulation of IL-1
expression.
Our data suggest a mechanism by
which SSD impairs wound healing.
Treatment with SSD alters the cytokine
milieu resulting in aberrant recruitment
and activation of macrophages. Histolo-
gical analysis revealed decreased
macrophage recruitment and impaired
collagen deposition and re-epithelializa-
tion. Clinical wound closure correlated
with these findings, with delayed clo-
sure in the SSD-treatment group. We
hypothesize that SSD alters gene expres-
sion of IL-1 family genes resulting in
impaired downstream cytokine produc-
tion and ultimately delayed wound
healing. In summary, these data suggest
a causal relationship by which SSD
retards wound healing, although further
investigations are necessary.
Two full-thickness 5-mm thermal
burns were induced on the dorsal sur-
face of BALB/c mice using a previously
described protocol (Macherla et al.,
2012). Mice were split into two
groups: untreated control (n¼56) and
SSD-treated (n¼46) (50ml of 1% SSD
cream per wound daily). Daily
photographs were taken, and Image J
software (US National Institutes of
Health, Bethesda, MD) was used to
assess change in wound area relative
to day 0. Mice were killed for histology
on days 3, 7, and 15. Histologic samples
were stained using H&E, Masson’s
trichrome, IBA-1, and MPO to
visualize morphology, collagen
deposition, macrophages, and neutro-
phils, respectively. Burn wounds were
collected for cytokine analysis (n¼10
wounds, 5 animals per group). Tissue
samples were analyzed in duplicate for
cytokine expression using Mouse
Cytokine Antibody Array (RayBiotech,
Norcross, GA) as per manufactures
guidelines. The intensity of each
cytokine signal was determined by
subtracting the background from the
total measured intensity using Quantity
One Software (Bio-Rad, Hercules, CA).
All protocols and experiments have
been approved by the Albert Einstein
College of Medicine Institutional
Review Board.
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